Revisione Critica Della Sindrome Da Disfunzione Epatica (Reversibile?) in Corso Di Neoplasia Renale

Abstract

Get full access to this article

View all access options for this article.

References

Boxer

R. G.

, Waisman

, Lieber

M. M.

, Mampaso

F. M.

, Skinner

D. G.

: Non metastatic hepatic dysfunction associated with renal carcinoma. J. Urol., 119; 468–471 (1978).

Darcy

D. A.

: Response of a serum glycoprotein to hyperplasia and tumor growth. Brit. J. Exper. Pathol., 45; 281–293 (1964).

Durocher

G. R.

: Alkaline phosphatase and hypernephroma. N. Engl. J. Med., 281; 1369–1370 (1969).

Fletcher

M. S.

, Packham

D. A.

, Pryor

J. P.

, Yates-Bell

A. J.

: Hepatic dysfunction in renal carcinoma. Brit. J. Urol., 53; 533–536 (1981).

Ramos

C. V.

, Taylor

H. B.

: Hepatic dysfunction associated with renal carcinoma. Cancer, 29; 1287–1292 (1972).

Stauffer

M. H.

: Nephrogenic hepatosplenomegaly. Gastroenterology, 40; 694 (1961).

Utz

D. C.

, Warren

M. N.

, Gregg

G. A.

, Ludwig

, Kelasis

P. P.

: Reversible hepatic dysfunction assiocated with hypernephroma. Mayo Clinic Proceed., 45; 161–169 (1970).

Vermillion

S. E.

, Morlock

C. G.

, Bartholomew

L. G.

, Kelasis

P. P.

: Nephrogenic hepatic dysfunction secondary to tumefactive xanthogranulomatous pyelonephritis. Ann. Surg., 171; 130–136 (1970).

Walsh

P. H.

, Kissane

G. M.

: Non-metastatic hypernephroma with reversible hepatic dysfunction. Arch. Intern. Med., 122; 214–222 (1968).